Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Ann Thor

Concepts (449)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
71
2022
2140
4.060
 Why?
Receptor, ErbB-2
28
2020
326
3.150
 Why?
Metformin
10
2018
315
2.150
 Why?
Receptors, Estrogen
17
2020
426
1.570
 Why?
Tamoxifen
10
2020
199
1.520
 Why?
Receptor, ErbB-3
8
2016
44
1.320
 Why?
Cell Proliferation
15
2018
2375
1.140
 Why?
Genes, erbB-2
8
2013
28
1.110
 Why?
Mammary Neoplasms, Experimental
6
2017
66
1.070
 Why?
Apoptosis
21
2018
2499
0.900
 Why?
Biomarkers, Tumor
14
2021
1173
0.730
 Why?
Cell Line, Tumor
22
2020
3202
0.710
 Why?
Thyroid Hormones
1
2020
55
0.690
 Why?
ErbB Receptors
6
2010
605
0.680
 Why?
Up-Regulation
3
2020
839
0.670
 Why?
Hormone Replacement Therapy
1
2020
92
0.650
 Why?
Immunohistochemistry
26
2020
1691
0.620
 Why?
Mammary Neoplasms, Animal
3
2018
30
0.610
 Why?
Triple Negative Breast Neoplasms
3
2016
197
0.600
 Why?
Disease-Free Survival
11
2020
645
0.590
 Why?
Caspases
5
2009
245
0.580
 Why?
Tumor Suppressor Protein p53
14
2011
509
0.550
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
69
0.530
 Why?
Prognosis
21
2020
3773
0.520
 Why?
Testicular Neoplasms
3
2023
103
0.520
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1344
0.510
 Why?
Antineoplastic Agents
10
2018
2054
0.510
 Why?
Claudins
1
2016
24
0.500
 Why?
Receptor, IGF Type 1
3
2016
65
0.480
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1556
0.470
 Why?
Trastuzumab
8
2016
101
0.470
 Why?
Transcriptome
1
2020
874
0.450
 Why?
Carcinogenesis
1
2016
213
0.440
 Why?
Carcinoma, Ductal, Breast
5
2002
82
0.440
 Why?
Estradiol
2
2009
494
0.420
 Why?
Cell Cycle
4
2013
589
0.420
 Why?
Hypoglycemic Agents
3
2017
1219
0.420
 Why?
Genistein
2
2010
14
0.410
 Why?
Lymphatic Metastasis
16
2021
320
0.400
 Why?
Receptors, Steroid
2
2012
50
0.400
 Why?
Doxorubicin
10
2011
328
0.400
 Why?
Antineoplastic Agents, Hormonal
5
2020
157
0.380
 Why?
Antimetabolites, Antineoplastic
1
2012
91
0.370
 Why?
Female
67
2022
68551
0.370
 Why?
Signal Transduction
15
2018
4926
0.350
 Why?
Drug Resistance, Neoplasm
9
2016
756
0.350
 Why?
Receptors, Progesterone
6
2020
343
0.350
 Why?
STAT3 Transcription Factor
1
2012
194
0.340
 Why?
Neoplasm Invasiveness
7
2016
483
0.330
 Why?
Genes, p53
5
2000
70
0.330
 Why?
Humans
88
2023
129266
0.330
 Why?
Neoplasm Proteins
5
2016
422
0.310
 Why?
Glucose
1
2013
1001
0.290
 Why?
Glycoproteins
2
2005
338
0.290
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
442
0.280
 Why?
Mammary Tumor Virus, Mouse
2
2004
44
0.280
 Why?
Mice, Transgenic
8
2018
2117
0.270
 Why?
Mice
17
2022
16915
0.270
 Why?
MCF-7 Cells
4
2020
116
0.260
 Why?
MicroRNAs
4
2021
676
0.260
 Why?
Carcinoma
4
1995
215
0.260
 Why?
Antibodies, Monoclonal
7
2013
1367
0.260
 Why?
Bromodeoxyuridine
2
1999
77
0.240
 Why?
Protein Kinase Inhibitors
3
2016
890
0.240
 Why?
Polymerase Chain Reaction
6
2021
1036
0.240
 Why?
Multivariate Analysis
8
2005
1497
0.240
 Why?
Radiation Tolerance
1
2005
98
0.230
 Why?
Xenograft Model Antitumor Assays
3
2020
812
0.230
 Why?
Tyrosine
2
2007
223
0.230
 Why?
Enzyme Activation
4
2009
812
0.230
 Why?
Animals
22
2022
35309
0.220
 Why?
Quinazolines
2
2016
244
0.220
 Why?
Phosphorylation
5
2011
1710
0.210
 Why?
Survival Analysis
8
2005
1269
0.210
 Why?
Cocarcinogenesis
1
2003
14
0.210
 Why?
Isoflavones
1
2003
25
0.210
 Why?
Cell Survival
5
2018
1075
0.210
 Why?
Paclitaxel
4
2015
217
0.210
 Why?
Seminoma
1
2023
17
0.210
 Why?
Chromosomes
1
2003
100
0.200
 Why?
Ki-67 Antigen
4
2014
108
0.200
 Why?
Chromosomes, Human, Pair 8
1
2002
35
0.200
 Why?
Cyclins
2
2000
89
0.190
 Why?
Gelsolin
1
2001
9
0.190
 Why?
Chromosome Aberrations
1
2002
148
0.190
 Why?
Orchiectomy
1
2021
67
0.180
 Why?
Cyclophosphamide
7
2011
232
0.180
 Why?
Retroperitoneal Neoplasms
1
2021
24
0.180
 Why?
Proto-Oncogene Proteins c-ets
2
2020
53
0.180
 Why?
Breast
4
2018
153
0.180
 Why?
Middle Aged
29
2021
31090
0.180
 Why?
Diet
3
2018
1212
0.170
 Why?
Rats
7
2022
5482
0.170
 Why?
DNA-Binding Proteins
3
2020
1446
0.170
 Why?
Obesity
4
2022
2879
0.170
 Why?
Caspase 3
4
2006
245
0.170
 Why?
Etoposide
1
2001
148
0.170
 Why?
Neoplasm Staging
8
2021
1290
0.170
 Why?
Cell Division
6
2005
796
0.170
 Why?
Neoplastic Stem Cells
2
2014
379
0.170
 Why?
Teratoma
1
2021
103
0.170
 Why?
TOR Serine-Threonine Kinases
3
2012
396
0.170
 Why?
Phosphatidylinositol 3-Kinases
3
2011
360
0.160
 Why?
Transcription Factors
3
2020
1647
0.160
 Why?
Mice, SCID
1
2020
350
0.160
 Why?
Drug Screening Assays, Antitumor
3
2016
193
0.160
 Why?
Proto-Oncogene Proteins
5
2008
635
0.160
 Why?
Carcinoma, Papillary
1
1999
77
0.160
 Why?
Mitotic Index
1
1999
26
0.160
 Why?
Ovarian Neoplasms
4
1995
489
0.150
 Why?
Mice, Inbred NOD
1
2020
588
0.150
 Why?
Receptors, Androgen
2
2017
147
0.150
 Why?
Chemotherapy, Adjuvant
5
2015
379
0.150
 Why?
Aromatase
1
2018
31
0.150
 Why?
Kaplan-Meier Estimate
1
2020
851
0.150
 Why?
Drug Synergism
3
2018
370
0.150
 Why?
Tumor Cells, Cultured
6
2009
942
0.150
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
52
0.150
 Why?
HSP90 Heat-Shock Proteins
1
2018
45
0.140
 Why?
Phenylthiohydantoin
2
2017
44
0.140
 Why?
Autism Spectrum Disorder
1
2023
386
0.140
 Why?
Antigens, Neoplasm
2
2009
308
0.140
 Why?
Down-Regulation
3
2010
636
0.140
 Why?
Ovariectomy
4
2022
135
0.140
 Why?
In Situ Hybridization, Fluorescence
4
2008
313
0.140
 Why?
Antibodies, Monoclonal, Humanized
5
2013
758
0.140
 Why?
Tumor Burden
4
2022
286
0.140
 Why?
Fluorouracil
5
2009
198
0.140
 Why?
Poly(ADP-ribose) Polymerases
2
2009
94
0.140
 Why?
Postmenopause
5
2022
350
0.140
 Why?
Estrogen Receptor alpha
2
2018
133
0.130
 Why?
Organic Cation Transport Proteins
1
2017
30
0.130
 Why?
Triazoles
1
2018
151
0.130
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
231
0.130
 Why?
Smad Proteins
1
2016
38
0.130
 Why?
Cathepsin D
2
2002
18
0.120
 Why?
Gene Knock-In Techniques
1
2016
53
0.120
 Why?
Calcitriol
1
2016
55
0.120
 Why?
Antibiotics, Antineoplastic
3
2009
123
0.120
 Why?
Ovary
1
2017
207
0.120
 Why?
Estrogens
1
2018
346
0.120
 Why?
Proteins
2
1992
941
0.120
 Why?
Protein Tyrosine Phosphatases
1
2016
169
0.120
 Why?
Gene Amplification
2
2009
105
0.120
 Why?
Fatty Acid Synthase, Type I
1
2014
11
0.110
 Why?
Mental Disorders
1
2023
1028
0.110
 Why?
Immunoradiometric Assay
1
1994
2
0.110
 Why?
Immunoprecipitation
2
2011
157
0.110
 Why?
Disease Progression
6
2018
2630
0.110
 Why?
Androgen Receptor Antagonists
1
2014
36
0.110
 Why?
Postpartum Period
2
2014
332
0.110
 Why?
Mice, Knockout
1
2020
2871
0.110
 Why?
Insulin-Like Growth Factor I
1
2016
307
0.110
 Why?
Androgen Antagonists
1
2014
79
0.100
 Why?
Receptor, ErbB-4
2
2010
19
0.100
 Why?
Transforming Growth Factor beta
1
2016
455
0.100
 Why?
Adenocarcinoma
3
2012
898
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
74
0.100
 Why?
Blotting, Western
3
2011
1204
0.100
 Why?
Vitamin D
1
2016
385
0.100
 Why?
Overnutrition
1
2012
30
0.100
 Why?
Nucleic Acid Hybridization
2
2003
189
0.100
 Why?
Aminosalicylic Acids
1
2012
5
0.100
 Why?
DNA, Neoplasm
6
2005
158
0.100
 Why?
Benzenesulfonates
1
2012
19
0.100
 Why?
RNA, Messenger
4
2016
2703
0.100
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
232
0.100
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
54
0.100
 Why?
Disease Models, Animal
4
2017
4057
0.090
 Why?
Gene Expression Profiling
2
2016
1688
0.090
 Why?
Chromones
1
2011
45
0.090
 Why?
Aged
14
2015
22032
0.090
 Why?
Genital Diseases, Female
1
1991
27
0.090
 Why?
Proportional Hazards Models
4
2005
1197
0.090
 Why?
Dasatinib
1
2011
54
0.090
 Why?
Fluoxymesterone
1
1991
2
0.090
 Why?
Mitosis
3
2001
180
0.090
 Why?
Thiazoles
1
2011
117
0.090
 Why?
Apoptosis Regulatory Proteins
1
2012
182
0.090
 Why?
Cohort Studies
2
2020
5409
0.090
 Why?
S Phase
2
2010
75
0.090
 Why?
Morpholines
1
2011
122
0.090
 Why?
Reagent Kits, Diagnostic
1
1991
43
0.090
 Why?
Adult
17
2021
35495
0.090
 Why?
Predictive Value of Tests
5
2011
1949
0.090
 Why?
Weight Gain
3
2022
509
0.090
 Why?
Genital Neoplasms, Female
1
1991
82
0.080
 Why?
Neoplasm Metastasis
5
2005
610
0.080
 Why?
Chromosomes, Human, Pair 17
3
2002
54
0.080
 Why?
Proto-Oncogenes
1
1989
29
0.080
 Why?
Aged, 80 and over
6
2002
7055
0.080
 Why?
Radioisotopes
1
1989
31
0.080
 Why?
Flow Cytometry
3
2007
1155
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
2011
0.080
 Why?
Follow-Up Studies
5
2020
4887
0.080
 Why?
DNA Topoisomerases, Type II
1
2009
43
0.080
 Why?
Anthracyclines
1
2009
49
0.080
 Why?
Treatment Outcome
5
2007
10202
0.070
 Why?
Gene Deletion
2
2002
380
0.070
 Why?
Pyrimidines
1
2011
459
0.070
 Why?
AMP-Activated Protein Kinases
1
2009
191
0.070
 Why?
RNA, Small Interfering
2
2007
591
0.070
 Why?
MAP Kinase Signaling System
1
2010
313
0.070
 Why?
Epithelial Cells
1
2014
1063
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
947
0.070
 Why?
Mutation
3
1995
3710
0.070
 Why?
Mice, Nude
1
2009
682
0.070
 Why?
Gene Dosage
1
2008
143
0.070
 Why?
Time Factors
4
2015
6543
0.070
 Why?
Protein Structure, Tertiary
1
2009
841
0.070
 Why?
Immunoenzyme Techniques
3
1999
214
0.070
 Why?
Energy Metabolism
1
2012
873
0.070
 Why?
Aging
4
2003
1774
0.070
 Why?
Proto-Oncogene Proteins c-akt
3
2016
431
0.070
 Why?
Enzyme Precursors
1
2006
14
0.060
 Why?
Cell Nucleus
4
2006
586
0.060
 Why?
Receptor, Notch1
1
2006
61
0.060
 Why?
Mitochondria
3
2008
877
0.060
 Why?
Multigene Family
2
2003
199
0.060
 Why?
Epigenesis, Genetic
1
2010
616
0.060
 Why?
Lamin Type B
1
2005
7
0.060
 Why?
Survival Rate
4
2020
1869
0.060
 Why?
Herpes Simplex
1
2006
92
0.060
 Why?
Age Factors
3
2003
3140
0.060
 Why?
Cell Nucleolus
1
2005
17
0.060
 Why?
Herpesvirus 1, Human
1
2006
86
0.060
 Why?
Benzamides
2
2017
207
0.060
 Why?
Nitriles
2
2017
172
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
117
0.060
 Why?
Feedback
1
2005
162
0.060
 Why?
Antineoplastic Agents, Phytogenic
2
2007
187
0.060
 Why?
RNA Interference
3
2015
450
0.060
 Why?
Tumor Microenvironment
2
2018
631
0.060
 Why?
Protein Kinases
1
2006
318
0.050
 Why?
Tacrolimus Binding Protein 1A
1
2003
8
0.050
 Why?
Adipose Tissue
2
2018
590
0.050
 Why?
Tacrolimus Binding Proteins
1
2003
27
0.050
 Why?
Rats, Wistar
2
2017
441
0.050
 Why?
Mice, Inbred Strains
1
2004
406
0.050
 Why?
Genes, Tumor Suppressor
1
2003
86
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
10
0.050
 Why?
Phytoestrogens
1
2003
17
0.050
 Why?
Estrogen Antagonists
1
2003
45
0.050
 Why?
Plant Preparations
1
2003
32
0.050
 Why?
Lymph Node Excision
2
2021
164
0.050
 Why?
Cell Line
2
2003
2779
0.050
 Why?
Actins
1
2005
411
0.050
 Why?
Chromosome Banding
1
2002
21
0.050
 Why?
Anticarcinogenic Agents
1
2003
77
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
30
0.050
 Why?
Mammary Glands, Animal
1
2003
120
0.050
 Why?
Rodentia
1
2022
48
0.050
 Why?
3' Untranslated Regions
2
2014
137
0.050
 Why?
Transfection
3
2015
915
0.050
 Why?
Trefoil Factor-1
2
1992
2
0.050
 Why?
alpha-Fetoproteins
1
2021
41
0.050
 Why?
Nuclear Proteins
2
2000
659
0.050
 Why?
Fallopian Tubes
2
1991
31
0.050
 Why?
In Situ Nick-End Labeling
1
2001
124
0.050
 Why?
Chorionic Gonadotropin
1
2021
79
0.050
 Why?
RNA, Catalytic
1
2002
185
0.040
 Why?
DNA Fragmentation
1
2001
44
0.040
 Why?
Plasmids
1
2002
358
0.040
 Why?
Sweden
1
2021
93
0.040
 Why?
Inhibitory Concentration 50
1
2001
86
0.040
 Why?
RNA Stability
1
2021
102
0.040
 Why?
Antigens, Nuclear
1
2000
20
0.040
 Why?
Neoplasm, Residual
1
2021
120
0.040
 Why?
Breast Diseases
1
2000
22
0.040
 Why?
Enhancer Elements, Genetic
1
2000
176
0.040
 Why?
Integrin beta3
2
2013
6
0.040
 Why?
Reproducibility of Results
2
2021
3080
0.040
 Why?
Tumor Suppressor Proteins
2
1992
314
0.040
 Why?
Telomerase
1
2001
233
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.040
 Why?
DNA Glycosylases
1
1998
5
0.040
 Why?
Methylnitrosourea
1
2018
7
0.040
 Why?
Loss of Function Mutation
1
2018
39
0.040
 Why?
Antibodies
1
2000
398
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
45
0.040
 Why?
Trans-Activators
1
2000
388
0.040
 Why?
Codon
3
1993
86
0.040
 Why?
Case-Control Studies
2
2023
3377
0.040
 Why?
Half-Life
1
2018
162
0.040
 Why?
NF-kappa B
1
2002
665
0.040
 Why?
Stromal Cells
1
2018
105
0.040
 Why?
Hyaluronan Receptors
1
1998
96
0.040
 Why?
Retrospective Studies
4
2005
14461
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
181
0.030
 Why?
Gene Expression
3
2013
1466
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Extracellular Matrix Proteins
1
1998
143
0.030
 Why?
Cell Movement
1
2001
944
0.030
 Why?
DNA Repair
1
1998
206
0.030
 Why?
Steroids
1
2017
158
0.030
 Why?
Antigens, CD
2
2014
489
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
12
0.030
 Why?
Oncogenes
1
2016
112
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
26
0.030
 Why?
Chromatography, Liquid
1
2017
424
0.030
 Why?
Oncogene Proteins
1
1995
55
0.030
 Why?
RNA
1
2001
880
0.030
 Why?
Analysis of Variance
2
2014
1288
0.030
 Why?
Homeodomain Proteins
1
2018
495
0.030
 Why?
Tosyl Compounds
1
2014
16
0.030
 Why?
Mammary Glands, Human
1
2014
64
0.030
 Why?
Integrin alpha6
1
2013
9
0.030
 Why?
Leukocyte Common Antigens
1
2014
82
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
60
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
286
0.030
 Why?
Mass Spectrometry
1
2017
713
0.030
 Why?
Testosterone
1
2017
372
0.030
 Why?
Parity
1
2014
120
0.030
 Why?
Premenopause
1
2014
120
0.030
 Why?
Anilides
1
2014
72
0.030
 Why?
Immunoassay
1
1994
107
0.030
 Why?
Transplantation, Heterologous
1
2014
192
0.030
 Why?
Neovascularization, Pathologic
1
1995
296
0.030
 Why?
Neoplasm Transplantation
1
2014
256
0.030
 Why?
Interleukin-6
1
2017
720
0.030
 Why?
bcl-2-Associated X Protein
2
2007
55
0.030
 Why?
Sirolimus
2
2006
266
0.030
 Why?
Organ Specificity
1
2013
295
0.030
 Why?
Neoplasms
2
2012
2449
0.030
 Why?
Brain Neoplasms
2
1993
1143
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2013
45
0.030
 Why?
Lactation
1
2014
169
0.030
 Why?
Immune System
1
2014
175
0.030
 Why?
Lipogenesis
1
2012
59
0.020
 Why?
Point Mutation
1
1993
224
0.020
 Why?
Molecular Targeted Therapy
1
2015
390
0.020
 Why?
Astrocytoma
1
1993
115
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Gene Knockdown Techniques
1
2013
316
0.020
 Why?
Young Adult
2
2021
12391
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1202
0.020
 Why?
Peritoneum
1
1991
41
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
53
0.020
 Why?
Mucins
1
1991
70
0.020
 Why?
Glycolysis
1
2012
311
0.020
 Why?
Blotting, Northern
1
2010
201
0.020
 Why?
Evaluation Studies as Topic
1
1991
173
0.020
 Why?
Hormones
1
1991
140
0.020
 Why?
Pilot Projects
1
2015
1584
0.020
 Why?
In Situ Hybridization
1
2010
296
0.020
 Why?
Cells, Cultured
2
2013
4077
0.020
 Why?
Soft Tissue Neoplasms
1
1991
112
0.020
 Why?
Pregnancy
2
2014
6390
0.020
 Why?
Precipitin Tests
1
1989
97
0.020
 Why?
Radionuclide Imaging
1
1989
123
0.020
 Why?
Odds Ratio
1
1992
1019
0.020
 Why?
Glioblastoma
1
1993
322
0.020
 Why?
Prospective Studies
1
2021
7123
0.020
 Why?
Risk Factors
1
2003
9745
0.020
 Why?
Protein Multimerization
1
2010
178
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
756
0.020
 Why?
Lymph Nodes
1
1991
470
0.020
 Why?
Drug Interactions
1
2009
393
0.020
 Why?
Cytochromes c
1
2007
59
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
68
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
13
0.020
 Why?
Caspase 8
1
2006
48
0.020
 Why?
Amino Acid Sequence
3
1998
2056
0.020
 Why?
Caspase 9
1
2006
56
0.020
 Why?
Cysteine Endopeptidases
1
2006
68
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
13
0.020
 Why?
Caspase 7
1
2006
22
0.020
 Why?
Male
3
2023
63512
0.020
 Why?
Eukaryotic Initiation Factor-4E
1
2006
27
0.020
 Why?
Isoenzymes
1
2007
302
0.020
 Why?
Vero Cells
1
2006
65
0.020
 Why?
Cytosol
1
2006
219
0.020
 Why?
Biomarkers
1
2017
3968
0.020
 Why?
Promoter Regions, Genetic
1
2010
1204
0.020
 Why?
Base Sequence
2
2003
2146
0.020
 Why?
Virus Assembly
1
2006
76
0.020
 Why?
Adolescent
2
2021
20313
0.010
 Why?
Taxoids
1
2004
98
0.010
 Why?
Protein Binding
1
2010
2120
0.010
 Why?
Protein Processing, Post-Translational
1
2006
454
0.010
 Why?
DNA, Complementary
1
2003
271
0.010
 Why?
Melanoma, Experimental
1
2003
107
0.010
 Why?
Americas
1
2002
24
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2002
29
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
78
0.010
 Why?
Endothelial Growth Factors
1
2002
63
0.010
 Why?
Lymphokines
1
2002
127
0.010
 Why?
Plasminogen Activator Inhibitor 1
1
2002
84
0.010
 Why?
Mice, Inbred C57BL
2
2003
5439
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
35
0.010
 Why?
Cell Adhesion
1
2003
452
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
55
0.010
 Why?
Gene Targeting
1
2002
82
0.010
 Why?
Europe
1
2002
363
0.010
 Why?
Exons
2
1993
341
0.010
 Why?
Templates, Genetic
1
2001
61
0.010
 Why?
Substrate Specificity
1
2002
368
0.010
 Why?
Molecular Sequence Data
2
1998
2835
0.010
 Why?
DNA, Superhelical
1
2000
11
0.010
 Why?
DNA Footprinting
1
2000
33
0.010
 Why?
Data Interpretation, Statistical
1
2002
336
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2002
374
0.010
 Why?
Mice, Inbred BALB C
1
2003
1247
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
17
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
111
0.010
 Why?
Macromolecular Substances
1
2000
216
0.010
 Why?
Pathology, Clinical
1
2000
36
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2002
530
0.010
 Why?
Gene Silencing
1
2000
190
0.010
 Why?
Multicenter Studies as Topic
1
2000
285
0.010
 Why?
Forecasting
1
2000
359
0.010
 Why?
Genetic Therapy
1
2000
288
0.010
 Why?
Receptors, Cell Surface
1
2000
380
0.010
 Why?
Binding Sites
1
2000
1250
0.010
 Why?
Nucleic Acid Conformation
1
2000
706
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
15
0.010
 Why?
ras Proteins
1
1998
144
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
48
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
56
0.010
 Why?
Immunoblotting
1
1997
305
0.010
 Why?
Societies, Medical
1
2000
744
0.010
 Why?
Adenine
1
1998
256
0.010
 Why?
Heterozygote
1
1996
272
0.010
 Why?
Hyaluronic Acid
1
1998
214
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
28
0.010
 Why?
Protein Isoforms
1
1997
389
0.010
 Why?
Cyclin D1
1
1995
63
0.010
 Why?
United States
2
2004
13826
0.010
 Why?
Melanoma
1
2002
729
0.010
 Why?
Factor VIII
1
1995
87
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1365
0.010
 Why?
Single-Blind Method
1
1995
271
0.010
 Why?
Observer Variation
1
1995
315
0.010
 Why?
Transcription, Genetic
1
2000
1416
0.010
 Why?
Alleles
1
1996
845
0.010
 Why?
Biopsy
1
1995
1092
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
53
0.010
 Why?
Peripheral Nerves
1
1991
69
0.010
 Why?
Risk Assessment
1
2000
3232
0.010
 Why?
DNA
1
1996
1396
0.010
 Why?
Protein Conformation
1
1993
861
0.010
 Why?
Polymorphism, Genetic
1
1993
639
0.010
 Why?
Lung Neoplasms
1
2002
2342
0.000
 Why?
Cerebral Cortex
1
1991
436
0.000
 Why?
Glioma
1
1991
347
0.000
 Why?
Child
1
1993
20785
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (449) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)